Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial
--------------------------------------------------------------------
Source: CNBC
Published: 2026-08-19 20:46 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Business & Economy, Crime & Justice
--------------------------------------------------------------------
Snippet:
An experimental personalized cancer vaccine from Merck and Moderna showed positive initial results in its first-ever late-stage trial, the companies announced Wednesday, bringing them one step closer to filing for approval of the treatment option.
--------------------------------------------------------------------